Acrivon Therapeutics - 53 Year Dividend History | ACRV
Historical dividend payout and yield for Acrivon Therapeutics (ACRV) since 1971. The current TTM dividend payout for Acrivon Therapeutics (ACRV) as of November 20, 2024 is $0.00. The current dividend yield for Acrivon Therapeutics as of November 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.199B |
$0.000B |
|
Acrivon Therapeutics Inc. is a clinical stage biopharmaceutical company developing precision oncology medicines which matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing Acrivon's proprietary proteomics-based patient responder identification platform, Acrivon Predictive Precision Proteomics. The company's lead candidate includes ACR-368. Acrivon Therapeutics Inc. is based in WATERTOWN, Mass.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
